What is Glasgold Group?
Established in the 1960s, The Glasgold Group has evolved into a premier destination for facial plastic surgery, anchored by the expertise of Drs. Mark and Robert Glasgold. For over two decades, the practice has distinguished itself through a commitment to natural-looking results and surgical artistry. By integrating advanced rhinoplasty, facelift, and injectable techniques, the group maintains a high-touch, patient-centric model that caters to a discerning global clientele. Their reputation is built upon a foundation of meticulous care and a legacy of excellence that bridges traditional surgical precision with modern aesthetic innovation.
How much funding has Glasgold Group raised?
Glasgold Group has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Glasgold Group
PPP
Public-Private Partnership
What's next for Glasgold Group?
With the recent influx of capital, The Glasgold Group is poised to enter a new phase of institutional scaling. The strategic deployment of these funds will likely focus on enhancing clinical infrastructure, expanding the reach of their proprietary surgical methodologies, and potentially integrating new technological advancements in facial rejuvenation. As the practice transitions from a legacy-focused boutique model to a more expansive, high-growth entity, the focus remains on maintaining the high standards of patient satisfaction that have defined their brand for over 25 years. This late-stage financing provides the necessary runway to solidify their leadership in the competitive landscape of specialized facial plastic surgery.
See full Glasgold Group company page
